| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 32 | 2025 | 642 | 8.200 |
Why?
|
| Regeneration | 14 | 2021 | 227 | 5.050 |
Why?
|
| Heart | 15 | 2023 | 703 | 4.620 |
Why?
|
| Myocardial Infarction | 12 | 2023 | 1068 | 3.010 |
Why?
|
| Organogenesis | 8 | 2025 | 84 | 2.460 |
Why?
|
| Homeodomain Proteins | 5 | 2019 | 586 | 2.190 |
Why?
|
| Signal Transduction | 21 | 2023 | 4848 | 2.050 |
Why?
|
| Phosphoproteins | 7 | 2019 | 454 | 1.840 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2019 | 625 | 1.810 |
Why?
|
| Cell Proliferation | 19 | 2023 | 2558 | 1.800 |
Why?
|
| Heart Diseases | 6 | 2019 | 517 | 1.740 |
Why?
|
| Transcription Factors | 12 | 2021 | 2716 | 1.740 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 500 | 1.700 |
Why?
|
| Cell Cycle Proteins | 10 | 2022 | 698 | 1.680 |
Why?
|
| MicroRNAs | 11 | 2018 | 941 | 1.620 |
Why?
|
| Animals | 77 | 2025 | 35916 | 1.500 |
Why?
|
| Eclampsia | 5 | 2017 | 29 | 1.400 |
Why?
|
| Fibroblasts | 6 | 2022 | 892 | 1.330 |
Why?
|
| Myocardium | 9 | 2021 | 914 | 1.160 |
Why?
|
| Actins | 2 | 2024 | 341 | 1.140 |
Why?
|
| Sinoatrial Node | 2 | 2020 | 24 | 1.120 |
Why?
|
| Pre-Eclampsia | 6 | 2019 | 230 | 1.120 |
Why?
|
| Mitochondria | 3 | 2024 | 752 | 1.080 |
Why?
|
| Cell Nucleus | 2 | 2021 | 689 | 1.050 |
Why?
|
| Mice | 43 | 2025 | 18888 | 1.020 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2025 | 1049 | 0.980 |
Why?
|
| Skull | 3 | 2022 | 145 | 0.950 |
Why?
|
| Atrial Fibrillation | 5 | 2025 | 700 | 0.900 |
Why?
|
| Cell Differentiation | 17 | 2025 | 2026 | 0.880 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2017 | 77 | 0.850 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 55 | 0.840 |
Why?
|
| Neural Crest | 2 | 2015 | 56 | 0.840 |
Why?
|
| Ependymoglial Cells | 2 | 2019 | 10 | 0.790 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2013 | 39 | 0.780 |
Why?
|
| Mice, Knockout | 18 | 2025 | 3978 | 0.780 |
Why?
|
| Chromatin | 4 | 2025 | 617 | 0.760 |
Why?
|
| Fibrosis | 3 | 2022 | 427 | 0.750 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2019 | 42 | 0.750 |
Why?
|
| Purkinje Fibers | 1 | 2021 | 7 | 0.720 |
Why?
|
| Microtubules | 1 | 2022 | 131 | 0.720 |
Why?
|
| Cellular Reprogramming | 2 | 2019 | 130 | 0.710 |
Why?
|
| Cell Fractionation | 1 | 2021 | 27 | 0.700 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 324 | 0.680 |
Why?
|
| Cytokinesis | 1 | 2020 | 22 | 0.680 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 1420 | 0.660 |
Why?
|
| Heart Conduction System | 1 | 2021 | 145 | 0.660 |
Why?
|
| Integrases | 1 | 2021 | 163 | 0.660 |
Why?
|
| Zebrafish | 1 | 2023 | 421 | 0.650 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2019 | 19 | 0.630 |
Why?
|
| Epigenomics | 1 | 2021 | 196 | 0.630 |
Why?
|
| Pregnancy Outcome | 3 | 2016 | 636 | 0.630 |
Why?
|
| Heart Valves | 1 | 2019 | 53 | 0.610 |
Why?
|
| Premature Birth | 3 | 2019 | 417 | 0.590 |
Why?
|
| Postpartum Period | 3 | 2017 | 231 | 0.590 |
Why?
|
| Secretory Vesicles | 1 | 2018 | 21 | 0.580 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 179 | 0.580 |
Why?
|
| Transcriptome | 6 | 2025 | 1134 | 0.580 |
Why?
|
| Single-Cell Analysis | 5 | 2025 | 356 | 0.560 |
Why?
|
| Adipogenesis | 1 | 2018 | 81 | 0.560 |
Why?
|
| Obstetrics | 2 | 2017 | 240 | 0.560 |
Why?
|
| Pregnancy | 23 | 2019 | 7593 | 0.540 |
Why?
|
| Pericardium | 1 | 2018 | 87 | 0.540 |
Why?
|
| Tocolysis | 1 | 2017 | 5 | 0.540 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 36 | 0.530 |
Why?
|
| Wound Healing | 2 | 2023 | 486 | 0.530 |
Why?
|
| HELLP Syndrome | 3 | 2012 | 17 | 0.520 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 85 | 0.510 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2018 | 167 | 0.510 |
Why?
|
| Humans | 51 | 2025 | 133202 | 0.510 |
Why?
|
| Sarcomeres | 2 | 2013 | 33 | 0.500 |
Why?
|
| Pulmonary Edema | 1 | 2016 | 60 | 0.500 |
Why?
|
| Heart Injuries | 1 | 2016 | 46 | 0.500 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 3361 | 0.490 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 109 | 0.490 |
Why?
|
| Mammals | 3 | 2023 | 282 | 0.490 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 241 | 0.480 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 231 | 0.480 |
Why?
|
| Mandible | 2 | 2015 | 82 | 0.470 |
Why?
|
| Phenotype | 3 | 2025 | 4571 | 0.470 |
Why?
|
| Antioxidants | 3 | 2016 | 336 | 0.450 |
Why?
|
| DNA-Binding Proteins | 6 | 2025 | 2144 | 0.450 |
Why?
|
| Aging | 2 | 2019 | 1273 | 0.450 |
Why?
|
| Infant Welfare | 1 | 2014 | 28 | 0.450 |
Why?
|
| Maternal Welfare | 1 | 2014 | 14 | 0.440 |
Why?
|
| Heart Failure | 3 | 2023 | 2413 | 0.440 |
Why?
|
| Embryo, Mammalian | 7 | 2022 | 467 | 0.440 |
Why?
|
| Face | 1 | 2015 | 189 | 0.440 |
Why?
|
| Cardiography, Impedance | 1 | 2014 | 10 | 0.430 |
Why?
|
| Cytoskeleton | 1 | 2015 | 172 | 0.430 |
Why?
|
| Mice, Transgenic | 7 | 2021 | 2503 | 0.430 |
Why?
|
| Transcription Factor AP-2 | 1 | 2013 | 22 | 0.420 |
Why?
|
| T-Box Domain Proteins | 4 | 2020 | 124 | 0.410 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 1751 | 0.410 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 129 | 0.410 |
Why?
|
| Heart Defects, Congenital | 3 | 2022 | 1888 | 0.410 |
Why?
|
| Insurance, Health | 1 | 2014 | 144 | 0.410 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 23 | 0.390 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 88 | 0.390 |
Why?
|
| Patient Safety | 1 | 2017 | 437 | 0.390 |
Why?
|
| Disease Management | 1 | 2016 | 567 | 0.390 |
Why?
|
| Epigenesis, Genetic | 3 | 2025 | 766 | 0.370 |
Why?
|
| Facial Bones | 1 | 2012 | 27 | 0.370 |
Why?
|
| Cell Cycle | 4 | 2019 | 619 | 0.370 |
Why?
|
| Medicaid | 1 | 2014 | 245 | 0.370 |
Why?
|
| Blood Pressure | 8 | 2014 | 1379 | 0.360 |
Why?
|
| Cleft Lip | 1 | 2013 | 133 | 0.360 |
Why?
|
| Cleft Palate | 1 | 2013 | 153 | 0.360 |
Why?
|
| Endothelial Cells | 3 | 2025 | 536 | 0.360 |
Why?
|
| Pancreas | 2 | 2025 | 230 | 0.350 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 420 | 0.340 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 446 | 0.340 |
Why?
|
| Dependovirus | 3 | 2021 | 153 | 0.330 |
Why?
|
| Ploidies | 2 | 2022 | 38 | 0.330 |
Why?
|
| Cell Division | 3 | 2023 | 767 | 0.330 |
Why?
|
| CRISPR-Cas Systems | 3 | 2019 | 298 | 0.330 |
Why?
|
| Heart Ventricles | 3 | 2021 | 786 | 0.320 |
Why?
|
| Hyperuricemia | 1 | 2010 | 41 | 0.320 |
Why?
|
| Hepatocytes | 2 | 2025 | 241 | 0.320 |
Why?
|
| Hemodynamics | 1 | 2014 | 857 | 0.320 |
Why?
|
| Receptor, Angiotensin, Type 1 | 4 | 2014 | 48 | 0.310 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4725 | 0.300 |
Why?
|
| Stem Cells | 6 | 2019 | 745 | 0.300 |
Why?
|
| Gene Expression | 1 | 2013 | 1598 | 0.300 |
Why?
|
| Genetic Therapy | 3 | 2021 | 728 | 0.300 |
Why?
|
| Pregnancy, Animal | 3 | 2014 | 75 | 0.290 |
Why?
|
| Swine | 2 | 2023 | 1199 | 0.290 |
Why?
|
| Female | 35 | 2025 | 71456 | 0.290 |
Why?
|
| Animals, Newborn | 4 | 2021 | 1039 | 0.290 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2022 | 249 | 0.290 |
Why?
|
| Cell Lineage | 2 | 2021 | 365 | 0.290 |
Why?
|
| Base Sequence | 6 | 2018 | 3147 | 0.290 |
Why?
|
| Repressor Proteins | 3 | 2022 | 870 | 0.290 |
Why?
|
| Stroke | 1 | 2016 | 1078 | 0.290 |
Why?
|
| Cardiomyopathies | 3 | 2025 | 510 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 4818 | 0.270 |
Why?
|
| Gene Deletion | 5 | 2019 | 806 | 0.260 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2632 | 0.260 |
Why?
|
| Hypertension | 4 | 2017 | 1348 | 0.260 |
Why?
|
| Alleles | 3 | 2021 | 1693 | 0.250 |
Why?
|
| Gene Editing | 3 | 2025 | 213 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 405 | 0.250 |
Why?
|
| Dioxygenases | 2 | 2024 | 65 | 0.240 |
Why?
|
| Gene Expression Profiling | 6 | 2025 | 1904 | 0.240 |
Why?
|
| Erythroid Cells | 2 | 2024 | 24 | 0.230 |
Why?
|
| Genes, Essential | 1 | 2025 | 43 | 0.230 |
Why?
|
| Morphogenesis | 2 | 2018 | 215 | 0.220 |
Why?
|
| Histidine | 1 | 2024 | 75 | 0.220 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 499 | 0.220 |
Why?
|
| Placenta | 7 | 2014 | 548 | 0.220 |
Why?
|
| Gene Targeting | 1 | 2025 | 185 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 2 | 2022 | 481 | 0.210 |
Why?
|
| Methylation | 1 | 2024 | 232 | 0.210 |
Why?
|
| Rats | 8 | 2021 | 3686 | 0.210 |
Why?
|
| Ischemia | 3 | 2012 | 380 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2025 | 244 | 0.210 |
Why?
|
| Apoptosis | 3 | 2022 | 1928 | 0.210 |
Why?
|
| Oxidative Stress | 4 | 2018 | 805 | 0.210 |
Why?
|
| Methyltransferases | 1 | 2024 | 83 | 0.210 |
Why?
|
| Receptors, Steroid | 2 | 2020 | 272 | 0.210 |
Why?
|
| Vascular Resistance | 2 | 2014 | 197 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2023 | 52 | 0.200 |
Why?
|
| Genetic Vectors | 2 | 2019 | 959 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2013 | 24 | 0.200 |
Why?
|
| Cells, Cultured | 5 | 2018 | 3124 | 0.200 |
Why?
|
| Image Cytometry | 1 | 2022 | 11 | 0.190 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 11 | 0.190 |
Why?
|
| Cell Line | 3 | 2018 | 2830 | 0.190 |
Why?
|
| HeLa Cells | 1 | 2024 | 838 | 0.190 |
Why?
|
| RNA, Messenger | 4 | 2017 | 2866 | 0.190 |
Why?
|
| Transgenes | 2 | 2025 | 344 | 0.190 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 520 | 0.190 |
Why?
|
| Embryonic Development | 2 | 2019 | 222 | 0.190 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 11 | 0.190 |
Why?
|
| Homocystinuria | 1 | 2022 | 27 | 0.180 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 45 | 0.180 |
Why?
|
| Histone Chaperones | 1 | 2021 | 12 | 0.180 |
Why?
|
| Cardiology | 2 | 2017 | 499 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2022 | 102 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2017 | 3714 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 641 | 0.180 |
Why?
|
| Immunomagnetic Separation | 1 | 2021 | 12 | 0.180 |
Why?
|
| Ribosomes | 1 | 2022 | 141 | 0.180 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2021 | 96 | 0.180 |
Why?
|
| Smad1 Protein | 2 | 2013 | 23 | 0.170 |
Why?
|
| Autoantibodies | 3 | 2014 | 461 | 0.170 |
Why?
|
| Cyclohexanones | 1 | 2020 | 19 | 0.170 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 55 | 0.170 |
Why?
|
| Ventricular Function | 1 | 2021 | 91 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 558 | 0.170 |
Why?
|
| Mesoderm | 3 | 2025 | 113 | 0.170 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 114 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 158 | 0.170 |
Why?
|
| Gestational Age | 3 | 2019 | 1230 | 0.170 |
Why?
|
| Tetralogy of Fallot | 1 | 2022 | 166 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 213 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2022 | 254 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2025 | 940 | 0.170 |
Why?
|
| Histones | 2 | 2021 | 572 | 0.160 |
Why?
|
| Developed Countries | 2 | 2017 | 42 | 0.160 |
Why?
|
| Monocytes | 1 | 2022 | 347 | 0.160 |
Why?
|
| Uterus | 3 | 2013 | 587 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 400 | 0.160 |
Why?
|
| Anemia | 1 | 2024 | 350 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 158 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 173 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 390 | 0.160 |
Why?
|
| Tamoxifen | 1 | 2021 | 375 | 0.160 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 3 | 0.160 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 18 | 0.160 |
Why?
|
| Endoderm | 1 | 2019 | 24 | 0.160 |
Why?
|
| Placenta Growth Factor | 1 | 2019 | 15 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 21 | 0.160 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2019 | 35 | 0.160 |
Why?
|
| Triage | 2 | 2017 | 148 | 0.160 |
Why?
|
| Early Diagnosis | 2 | 2018 | 198 | 0.160 |
Why?
|
| Saccule and Utricle | 1 | 2019 | 12 | 0.160 |
Why?
|
| Infant Mortality | 2 | 2010 | 180 | 0.150 |
Why?
|
| Pyridines | 1 | 2020 | 249 | 0.150 |
Why?
|
| Diploidy | 1 | 2019 | 39 | 0.150 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 272 | 0.150 |
Why?
|
| Hair Cells, Auditory | 1 | 2019 | 65 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2019 | 622 | 0.150 |
Why?
|
| Electron Transport Complex IV | 1 | 2018 | 41 | 0.150 |
Why?
|
| Gene Regulatory Networks | 4 | 2025 | 398 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 112 | 0.150 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2018 | 21 | 0.140 |
Why?
|
| Action Potentials | 2 | 2019 | 495 | 0.140 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 23 | 0.140 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2018 | 29 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2019 | 124 | 0.140 |
Why?
|
| Trans-Activators | 3 | 2019 | 832 | 0.140 |
Why?
|
| Mutation | 7 | 2022 | 6314 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 116 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 205 | 0.140 |
Why?
|
| Binding Sites | 1 | 2021 | 1360 | 0.140 |
Why?
|
| Heart Rate | 1 | 2020 | 581 | 0.140 |
Why?
|
| Olfactory Bulb | 1 | 2018 | 103 | 0.140 |
Why?
|
| Quality Control | 1 | 2017 | 123 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3937 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2014 | 1245 | 0.130 |
Why?
|
| Fetal Heart | 1 | 2018 | 135 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 47 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 37 | 0.130 |
Why?
|
| Neuroglia | 1 | 2019 | 214 | 0.130 |
Why?
|
| Health Priorities | 1 | 2017 | 39 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 699 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 180 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1118 | 0.130 |
Why?
|
| Sumoylation | 1 | 2017 | 41 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2018 | 223 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2018 | 622 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 673 | 0.130 |
Why?
|
| Heart Atria | 1 | 2019 | 334 | 0.130 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 30 | 0.130 |
Why?
|
| Cardiotoxicity | 1 | 2016 | 39 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 105 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2017 | 77 | 0.130 |
Why?
|
| Electron Transport | 1 | 2016 | 57 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 199 | 0.120 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 57 | 0.120 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 24 | 0.120 |
Why?
|
| Health Services Research | 1 | 2017 | 187 | 0.120 |
Why?
|
| Women's Health | 1 | 2017 | 149 | 0.120 |
Why?
|
| Embryo Loss | 1 | 2015 | 26 | 0.120 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 115 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2017 | 181 | 0.120 |
Why?
|
| Disease Progression | 1 | 2022 | 2246 | 0.120 |
Why?
|
| Young Adult | 4 | 2019 | 9973 | 0.120 |
Why?
|
| Emergency Medicine | 1 | 2017 | 161 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2018 | 360 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 248 | 0.120 |
Why?
|
| Retina | 1 | 2019 | 495 | 0.120 |
Why?
|
| Outpatients | 1 | 2017 | 276 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 140 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 119 | 0.120 |
Why?
|
| Mice, Inbred mdx | 1 | 2015 | 45 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2018 | 510 | 0.120 |
Why?
|
| Endothelin-1 | 2 | 2012 | 45 | 0.120 |
Why?
|
| RNA Interference | 2 | 2014 | 540 | 0.120 |
Why?
|
| Hydroxyprogesterones | 1 | 2014 | 5 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 79 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2016 | 244 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 392 | 0.110 |
Why?
|
| Albinism | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 2066 | 0.110 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 6 | 0.110 |
Why?
|
| Uterine Artery | 1 | 2014 | 29 | 0.110 |
Why?
|
| Pigmentation | 1 | 2014 | 36 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2015 | 244 | 0.110 |
Why?
|
| Monophenol Monooxygenase | 1 | 2014 | 25 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 189 | 0.110 |
Why?
|
| Cell Physiological Phenomena | 1 | 2014 | 17 | 0.110 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2014 | 9 | 0.110 |
Why?
|
| Liver | 2 | 2025 | 1852 | 0.110 |
Why?
|
| Endonucleases | 1 | 2014 | 56 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 88 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 152 | 0.110 |
Why?
|
| Progestins | 1 | 2014 | 51 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 633 | 0.110 |
Why?
|
| Genome | 1 | 2017 | 527 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 418 | 0.110 |
Why?
|
| Consensus | 1 | 2017 | 699 | 0.100 |
Why?
|
| Thorax | 1 | 2014 | 73 | 0.100 |
Why?
|
| Male | 13 | 2025 | 65411 | 0.100 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 86 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 240 | 0.100 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2013 | 18 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 571 | 0.100 |
Why?
|
| Mullerian Ducts | 1 | 2013 | 46 | 0.100 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 189 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2014 | 123 | 0.100 |
Why?
|
| Adult | 6 | 2019 | 31742 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2015 | 237 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2015 | 349 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 171 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 243 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2015 | 276 | 0.100 |
Why?
|
| Models, Biological | 1 | 2018 | 1522 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 1338 | 0.100 |
Why?
|
| Reference Values | 1 | 2014 | 724 | 0.100 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 242 | 0.100 |
Why?
|
| Mosaicism | 1 | 2014 | 249 | 0.100 |
Why?
|
| Headache | 1 | 2013 | 109 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1148 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8633 | 0.090 |
Why?
|
| Neural Tube Defects | 1 | 2015 | 359 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2015 | 516 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 1840 | 0.090 |
Why?
|
| beta Catenin | 1 | 2013 | 228 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 438 | 0.090 |
Why?
|
| Biomarkers | 4 | 2019 | 3409 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2012 | 130 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 351 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 715 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 544 | 0.090 |
Why?
|
| Plasma Exchange | 1 | 2012 | 89 | 0.090 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 261 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 77 | 0.090 |
Why?
|
| Cesarean Section | 1 | 2014 | 403 | 0.080 |
Why?
|
| Apgar Score | 1 | 2010 | 49 | 0.080 |
Why?
|
| Risk Factors | 4 | 2018 | 10935 | 0.080 |
Why?
|
| Parity | 1 | 2010 | 87 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2012 | 628 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2010 | 120 | 0.080 |
Why?
|
| United States | 2 | 2017 | 11658 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2013 | 17493 | 0.080 |
Why?
|
| Epithelium | 2 | 2013 | 362 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 386 | 0.080 |
Why?
|
| Calcium | 1 | 2014 | 1085 | 0.080 |
Why?
|
| Stillbirth | 1 | 2010 | 102 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2018 | 13069 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 510 | 0.080 |
Why?
|
| Serum Response Factor | 1 | 2008 | 29 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2013 | 923 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 931 | 0.070 |
Why?
|
| Birth Weight | 1 | 2010 | 355 | 0.070 |
Why?
|
| Neurons | 1 | 2018 | 2040 | 0.070 |
Why?
|
| Muscle Development | 2 | 2008 | 77 | 0.070 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 181 | 0.070 |
Why?
|
| Ovary | 2 | 2007 | 385 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2008 | 244 | 0.070 |
Why?
|
| Smad5 Protein | 1 | 2007 | 22 | 0.070 |
Why?
|
| Spleen | 2 | 2024 | 288 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2019 | 6579 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1849 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 130 | 0.060 |
Why?
|
| Decidua | 1 | 2007 | 142 | 0.060 |
Why?
|
| Branchial Region | 1 | 2005 | 8 | 0.060 |
Why?
|
| Adolescent | 3 | 2019 | 20594 | 0.060 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2025 | 11 | 0.060 |
Why?
|
| Testis | 1 | 2007 | 433 | 0.060 |
Why?
|
| Comorbidity | 1 | 2010 | 1609 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 2025 | 55 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3748 | 0.060 |
Why?
|
| Hydrolases | 1 | 2025 | 61 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 737 | 0.060 |
Why?
|
| Atrial Appendage | 1 | 2025 | 51 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2188 | 0.060 |
Why?
|
| Arteries | 1 | 2005 | 229 | 0.060 |
Why?
|
| Extremities | 1 | 2004 | 87 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2025 | 439 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 271 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3433 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2025 | 150 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2013 | 5175 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2025 | 150 | 0.050 |
Why?
|
| Child | 1 | 2023 | 25889 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 813 | 0.050 |
Why?
|
| Incidence | 1 | 2010 | 3376 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 816 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2018 | 478 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cyclic N-Oxides | 2 | 2012 | 12 | 0.050 |
Why?
|
| Spin Labels | 2 | 2012 | 21 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2012 | 62 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 63 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2014 | 897 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 76 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2975 | 0.040 |
Why?
|
| DNA Repair | 1 | 2025 | 573 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 55 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2022 | 174 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 50 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2021 | 61 | 0.040 |
Why?
|
| Brain | 2 | 2025 | 3216 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3869 | 0.040 |
Why?
|
| Iron | 1 | 2024 | 303 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 55 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 47 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2015 | 238 | 0.040 |
Why?
|
| Rituximab | 2 | 2012 | 165 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 955 | 0.040 |
Why?
|
| DNA Demethylation | 1 | 2019 | 10 | 0.040 |
Why?
|
| Models, Animal | 2 | 2012 | 480 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Infertility, Female | 2 | 2013 | 151 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 226 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 61 | 0.040 |
Why?
|
| Perinatal Death | 1 | 2019 | 28 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 68 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 841 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 119 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1018 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 178 | 0.040 |
Why?
|
| North America | 1 | 2019 | 265 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1546 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 677 | 0.040 |
Why?
|
| Cochlea | 1 | 2019 | 89 | 0.040 |
Why?
|
| Infant | 1 | 2014 | 13258 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 248 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 154 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 296 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 1038 | 0.040 |
Why?
|
| Interneurons | 1 | 2018 | 147 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 363 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 605 | 0.030 |
Why?
|
| Slovenia | 1 | 2016 | 1 | 0.030 |
Why?
|
| Czech Republic | 1 | 2016 | 12 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 6526 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 57 | 0.030 |
Why?
|
| New Zealand | 1 | 2016 | 60 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2017 | 146 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 103 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2016 | 36 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 157 | 0.030 |
Why?
|
| California | 1 | 2016 | 141 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 698 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 18 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 377 | 0.030 |
Why?
|
| International Agencies | 1 | 2015 | 30 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 90 | 0.030 |
Why?
|
| Progesterone Congeners | 1 | 2014 | 6 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 374 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 462 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 280 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 808 | 0.030 |
Why?
|
| Melanins | 1 | 2014 | 19 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2950 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2014 | 21 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 401 | 0.030 |
Why?
|
| Zygote | 1 | 2014 | 30 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 107 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2156 | 0.030 |
Why?
|
| Nitrates | 1 | 2014 | 33 | 0.030 |
Why?
|
| Nitrites | 1 | 2014 | 49 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 466 | 0.030 |
Why?
|
| Vasodilation | 1 | 2014 | 176 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 240 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 87 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2314 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 201 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 276 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 562 | 0.030 |
Why?
|
| Myometrium | 1 | 2013 | 48 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 191 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 354 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 175 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2014 | 390 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1456 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 251 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 394 | 0.020 |
Why?
|
| Isoprostanes | 1 | 2012 | 3 | 0.020 |
Why?
|
| Receptor, Endothelin A | 1 | 2012 | 13 | 0.020 |
Why?
|
| Endothelin A Receptor Antagonists | 1 | 2012 | 8 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 1140 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 774 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 696 | 0.020 |
Why?
|
| Losartan | 1 | 2012 | 34 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 2012 | 41 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 500 | 0.020 |
Why?
|
| Aged | 2 | 2025 | 21480 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 1083 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 907 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 57 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 115 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 315 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1244 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 29020 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 241 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 45 | 0.020 |
Why?
|
| Sarcoma | 1 | 2013 | 209 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2012 | 185 | 0.020 |
Why?
|
| Global Health | 1 | 2015 | 614 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 112 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 289 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1663 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 623 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2008 | 11 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2008 | 86 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 1580 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1314 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1825 | 0.020 |
Why?
|
| Smad8 Protein | 1 | 2007 | 6 | 0.020 |
Why?
|
| Sertoli Cell Tumor | 1 | 2007 | 8 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 1 | 2007 | 39 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 239 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 175 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 71 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 131 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 131 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2007 | 224 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 224 | 0.020 |
Why?
|
| Pharynx | 1 | 2005 | 69 | 0.020 |
Why?
|
| Fertility | 1 | 2007 | 270 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 317 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2007 | 235 | 0.010 |
Why?
|
| COUP Transcription Factors | 1 | 2004 | 43 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 1374 | 0.010 |
Why?
|
| Blastocyst | 1 | 2004 | 79 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 786 | 0.010 |
Why?
|
| COUP Transcription Factor II | 1 | 2004 | 117 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 456 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 560 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 545 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 908 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1747 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 2115 | 0.010 |
Why?
|